Dose of reality on drug patents


DEBATES on how to improve healthcare in developing countries often start from the same premise – patents can potentially raise drug prices so they should be abolished for better public health.

In the early 2000s, this argument drove the campaign against patents on HIV drugs in South Africa. This week, it is motivating campaigners against the Regional Comprehensive Economic Partnership in Asia, a proposed Free Trade Agreement among 16 Asian countries that may impose new intellectual requirements.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Letters

Time to consider adopting a ‘Living with floods’ mindset
Preparing workplaces for extreme weather conditions
Make Sustainable Haze Fund work on the ground
Asean Must Move Beyond Ceremonies to Meaningful Cooperation
What a small seller wants from Malaysia’s new e-commerce law
Gaza: A ceasefire is not peace
The Poch Project: Can Mauricio save United from themselves?
A home in every sense, except for stamp duty relief
Incomes are rising, but are Malaysians better off?
A ministry for an ageing nation

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read